-
Je něco špatně v tomto záznamu ?
ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology
D. Fischerova, F. Planchamp, JL. Alcázar, P. Dundr, E. Epstein, A. Felix, F. Frühauf, G. Garganese, I. Salvesen Haldorsen, D. Jurkovic, R. Kocian, D. Lengyel, F. Mascilini, A. Stepanyan, M. Stukan, S. Timmerman, T. Vanassche, ZY. Ng, U. Scovazzi
Jazyk angličtina Země Spojené státy americké
Typ dokumentu konsensus - konference, časopisecké články, přehledy
NLK
ProQuest Central
od 2018-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2018-01-01 do Před 6 měsíci
- MeSH
- gynekologie normy MeSH
- intervenční ultrasonografie * metody normy MeSH
- konsensus MeSH
- lékařská onkologie normy MeSH
- lidé MeSH
- nádory ženských pohlavních orgánů * patologie diagnostické zobrazování MeSH
- ultrazvukem navigovaná biopsie * metody normy MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- přehledy MeSH
The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) with the European Society of Gynaecological Oncology (ESGO) jointly developed clinically relevant and evidence-based statements on performing ultrasound-guided biopsies in gynecological oncology. The objective of this Consensus Statement is to assist clinicians, including gynecological sonographers, gynecological oncologists and radiologists, to achieve the best standards of practice in ultrasound-guided biopsy procedures. ISUOG/ESGO nominated a multidisciplinary international group of 16 experts who have demonstrated leadership in the use of ultrasound-guided biopsy in the clinical management of patients with gynecological cancer. In addition, two early-career gynecological fellows were nominated to participate from the European Network of Young Gynae Oncologists (ENYGO) within ESGO and from ISUOG. The group also included a patient representative from the European Network of Gynaecological Cancer Advocacy Groups. The document is divided into six sections: (1) general recommendations; (2) image-guided biopsy (imaging guidance, sampling methods); (3) indications and contraindications; (4) technique; (5) reporting; and (6) training and quality assurance. To ensure that the statements are evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on this review of the literature. During a conference call, the whole group discussed each preliminary statement, and a first round of voting was carried out. The group achieved consensus on all 46 preliminary statements without the need for revision. These ISUOG/ESGO statements on ultrasound-guided biopsy in gynecological oncology, together with a summary of the evidence supporting each statement, are presented herein. This Consensus Statement is supplemented by detailed narrated videoclips presenting different approaches and indications for ultrasound-guided biopsy, a patient leaflet, and an extended version which includes a detailed review of the evidence.
Department of Cardiovascular Diseases University Hospitals Leuven Leuven Belgium
Department of Clinical Science and Education Karolinska Institutet Södersjukhuset Stockholm Sweden
Department of Development and Regeneration KU Leuven Leuven Belgium
Department of Gynaecological Oncology KK Women's and Children's Hospital Singapore
Department of Gynaecology National Institute of Oncology Budapest Hungary
Department of Gynecological Oncology Pomeranian Hospitals Gdynia Poland
Doctoral School of Clinical Medicine University of Szeged Szeged Hungary
EGA Institute for Women's Health University College London London UK
Gynecologic Oncology Service Nairi Medical Center National Institute of Health Yerevan Armenia
Hospital QuirónSalud Málaga Spain
Institut Bergonie Bordeaux France
Instituto Portugues de Oncologia de Lisboa Francisco Gentil Lisbon Portugal
Section for Radiology Department of Clinical Medicine University of Bergen Bergen Norway
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016237
- 003
- CZ-PrNML
- 005
- 20250731091627.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijgc.2025.101732 $2 doi
- 035 __
- $a (PubMed)40121152
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fischerova, D $u Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Electronic address: daniela.fischerova@vfn.cz
- 245 10
- $a ISUOG/ESGO Consensus Statement on ultrasound-guided biopsy in gynecological oncology / $c D. Fischerova, F. Planchamp, JL. Alcázar, P. Dundr, E. Epstein, A. Felix, F. Frühauf, G. Garganese, I. Salvesen Haldorsen, D. Jurkovic, R. Kocian, D. Lengyel, F. Mascilini, A. Stepanyan, M. Stukan, S. Timmerman, T. Vanassche, ZY. Ng, U. Scovazzi
- 520 9_
- $a The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) with the European Society of Gynaecological Oncology (ESGO) jointly developed clinically relevant and evidence-based statements on performing ultrasound-guided biopsies in gynecological oncology. The objective of this Consensus Statement is to assist clinicians, including gynecological sonographers, gynecological oncologists and radiologists, to achieve the best standards of practice in ultrasound-guided biopsy procedures. ISUOG/ESGO nominated a multidisciplinary international group of 16 experts who have demonstrated leadership in the use of ultrasound-guided biopsy in the clinical management of patients with gynecological cancer. In addition, two early-career gynecological fellows were nominated to participate from the European Network of Young Gynae Oncologists (ENYGO) within ESGO and from ISUOG. The group also included a patient representative from the European Network of Gynaecological Cancer Advocacy Groups. The document is divided into six sections: (1) general recommendations; (2) image-guided biopsy (imaging guidance, sampling methods); (3) indications and contraindications; (4) technique; (5) reporting; and (6) training and quality assurance. To ensure that the statements are evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on this review of the literature. During a conference call, the whole group discussed each preliminary statement, and a first round of voting was carried out. The group achieved consensus on all 46 preliminary statements without the need for revision. These ISUOG/ESGO statements on ultrasound-guided biopsy in gynecological oncology, together with a summary of the evidence supporting each statement, are presented herein. This Consensus Statement is supplemented by detailed narrated videoclips presenting different approaches and indications for ultrasound-guided biopsy, a patient leaflet, and an extended version which includes a detailed review of the evidence.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a konsensus $7 D032921
- 650 12
- $a nádory ženských pohlavních orgánů $x patologie $x diagnostické zobrazování $7 D005833
- 650 _2
- $a gynekologie $x normy $7 D006176
- 650 12
- $a ultrazvukem navigovaná biopsie $x metody $x normy $7 D061705
- 650 _2
- $a lékařská onkologie $x normy $7 D008495
- 650 12
- $a intervenční ultrasonografie $x metody $x normy $7 D018084
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Planchamp, F $u Institut Bergonie, Bordeaux, France
- 700 1_
- $a Alcázar, J L $u University of Navarra, Pamplona, Spain; Hospital QuirónSalud, Málaga, Spain
- 700 1_
- $a Dundr, P $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Epstein, E $u Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden
- 700 1_
- $a Felix, A $u iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
- 700 1_
- $a Frühauf, F $u Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Garganese, G $u Unità Operativa di Chirurgia dei Organi Genitali Esterni Femminili, Divisione di Ginecologia Oncologica, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Gemelli Women Health Center for Digital and Personalized Medicine, Dipartimento Scienze della Vita e Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Salvesen Haldorsen, I $u Mohn Medical Imaging and Visualization Centre (MMIV), Department of Radiology, Haukeland University Hospital, Bergen, Norway; Section for Radiology, Department of Clinical Medicine, University of Bergen, Bergen, Norway
- 700 1_
- $a Jurkovic, D $u EGA Institute for Women's Health, University College London, London, UK
- 700 1_
- $a Kocian, R $u Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Lengyel, D $u Department of Gynaecology, National Institute of Oncology, Budapest, Hungary; Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary
- 700 1_
- $a Mascilini, F $u Unità Operativa di Chirurgia dei Organi Genitali Esterni Femminili, Divisione di Ginecologia Oncologica, Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- 700 1_
- $a Stepanyan, A $u Gynecologic Oncology Service, Nairi Medical Center, National Institute of Health, Yerevan, Armenia
- 700 1_
- $a Stukan, M $u Department of Gynecological Oncology, Pomeranian Hospitals (Szpitale Pomorskie), Gdynia, Poland; Clinic of Surgical Oncology, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Timmerman, S $u Department of Development and Regeneration, KU Leuven, Leuven, Belgium
- 700 1_
- $a Vanassche, T $u Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a Ng, Z Yuan $u Department of Gynaecological Oncology, KK Women's and Children's Hospital, Singapore
- 700 1_
- $a Scovazzi, U $u Academic Unit of Obstetrics and Gynecology, Hospital Polyclinic San Martino and University of Genoa, Genoa, Italy
- 773 0_
- $w MED00009896 $t International journal of gynecological cancer $x 1525-1438 $g Roč. 35, č. 4 (2025), s. 101732
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40121152 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091622 $b ABA008
- 999 __
- $a ok $b bmc $g 2366819 $s 1253362
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 35 $c 4 $d 101732 $e 20250321 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
- LZP __
- $a Pubmed-20250708
